Top Industry Leaders in the Alagille Syndrome Market
Latest Alagille Syndrome Companies Updates:
CANbridge Pharma secures marketing approval for LIVMARLI in Hong Kong: This September 2023 approval marks a significant step towards broader access to the medication for patients with Alagille Syndrome in the region.
Patient advocacy groups like the Alagille Syndrome Alliance and Chiari & Associates for Alagille Syndrome (CAFAS) play a vital role in raising awareness, providing support and resources, and funding research for improved diagnosis, treatment, and cure for Alagille Syndrome.
Online communities and forums offer valuable information and connection for individuals living with Alagille Syndrome and their families.
List of Alagille Syndrome Key companies in the market:
- Sanofi AG
- Teva Pharmaceutical Industries Ltd.
- Allergen Plc
- Lannett
- Albireo Pharma, Inc.
- AstraZeneca Plc
- Novartis AG
- Pfizer, Inc.
- Shire
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc